Article
The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa.
Scientific reports - 25 Nov 2015
Song Qingkun, Zhou Xinna, Yu Jing, Dong Ningning, Wang Xiaoli, Yang Huabing, Ren Jun, Lyerly H Kim
Abstract excerpt
This study investigated interactive effects of CYP2B6 genotypes and liver metastasis on the prognosis of metastatic breast cancer patients who received combined chemotherapy of docetaxel and thiotepa. Totally 153 patients were retrospectively genotyped rs8192719 (c.1294 + 53C > T) and rs2279343 (c.785A > G). Kaplan-Meier method and Cox Proportional Hazard Regression model were used to estimate the survival....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
